Drug Trial News

RSS

Omega-3 fatty acids ineffective for managing Crohn's disease

An international study led by Dr. Brian Feagan of Robarts Research Institute at The University of Western Ontario in London, Canada has found that omega-3 fatty acids are ineffective for managing Crohn's disease.

9 Apr 2008

Negligent, attentive mouse mothers show biological differences

In mice, child neglect is a product of both nature and nurture, according to a new study.

9 Apr 2008

Lower target levels for blood pressure, LDL-cholesterol may provide cardiovascular benefits

Patients with diabetes who reduced their blood pressure and LDL-cholesterol to below standard target levels had a greater decrease in carotid artery wall thickness, but did not have a significant difference in cardiovascular disease events than patients who had recommended blood pressure and LDL-cholesterol levels, according to a study in the April 9 issue of JAMA, the Journal of the American Medical Association.

9 Apr 2008

Increasing positive experiences decreases depression symptoms in patients with multiple sclerosis

Depression is prevalent among people living with chronic diseases, such as multiple sclerosis (MS). Although most people with MS live normal lives, they must manage symptoms and treatments that cause increased emotional and psychological stress on a daily basis.

9 Apr 2008

High-dose chemo does not improve survival in small cell lung cancer

Small cell lung cancer (SCLC) patients treated with high-dose chemotherapy did not have better survival rates than those treated with standard doses, according to a randomized controlled trial published online April 8 in the Journal of the National Cancer Institute .

9 Apr 2008

Rreishi mushroom and green tea for cancer prevention

Both the reishi mushroom (Ganoderma lucidum; Lingzhi) and green tea have long held a place in traditional medicine in China and other Asian countries, for the general promotion of health and long life and for the treatment of specific diseases.

9 Apr 2008

Diabetes drug may hold potential as treatment for epilepsy, using same mechanism as ketogenic diet

Two years ago, University of Wisconsin-Madison scientists reported they had suppressed epileptic seizures in rats by giving them a glycolytic-inhibitor, inhibiting the brain's ability to turn sugar into excess energy and blocking the expression of seizure-related genes.

9 Apr 2008

Cutting unnecessary treatment for blood disorder in pregnancy

A new test for identifying a mismatch between the blood of a pregnant woman and her baby is accurate, feasible, and could substantially reduce unnecessary treatment, finds a Bristol study published on bmj.com.

9 Apr 2008

Combination therapy improves survival time for patients with more advanced liver cancer

Combining a type of chemotherapy with radiothermal therapy resulted in longer survival time for patients with advanced liver cancer, compared to receiving the therapies alone, according to a study in the April 9 issue of JAMA, the Journal of the American Medical Association.

9 Apr 2008

Cholesterol, blood pressure control may reverse atherosclerosis in adults with diabetes

Aggressively lowering cholesterol and blood pressure levels below current targets in adults with type 2 diabetes may help to prevent – and possibly reverse – hardening of the arteries, according to new research supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health.

9 Apr 2008

Back pain problems may be more a matter of genetics than physical strain

What do you learn by looking at the spines of hundreds of Finnish twins?

9 Apr 2008

Angina drug ranolazine potentially useful against heart rhythm disorders

A recently approved angina drug may also represent a powerful new treatment for a rare hereditary syndrome that places teens at risk for sudden cardiac death, according to research presented on April 1st at the 57th Annual Scientific Sessions of the American College of Cardiology (ACC) in Chicago.

9 Apr 2008

Apples lower risk for metabolic syndrome

Not eating your apple a day? Perhaps you should be. Adults who eat apples, apple juice and applesauce have a significantly reduced risk of metabolic syndrome, a cluster of health problems that are linked to numerous chronic diseases such as diabetes and cardiovascular disease.

9 Apr 2008

Kidney cancer deaths show overall decline in Europe but study reveals wide variations between countries

Overall deaths from kidney cancer have now fallen across Europe after peaking in the early 1990s, according to a detailed analysis of mortality rates for 32 countries published in the urology journal BJU International.

9 Apr 2008

Parkinson transplants survive at least 16 years

Transplanted cells can survive in the brain for over one and half decade. However, some of the transplanted cells developed Parkinson-like features which is very surprising.

9 Apr 2008

Artifical food colours make kids hyperactive

A study by researchers in Britain suggests that artificial colour added to food and beverages could cause hyperactivity.

9 Apr 2008

Benefits of some cancer drugs exaggerated because trials were stopped early

Italian scientists say the benefits of some cancer drugs may be exaggerated as a rising number of trials are stopped early.

9 Apr 2008

TVs in teen's bedrooms bad for many reasons

University of Minnesota School of Public Health researchers have found that older adolescents who have a bedroom television are less likely to engage in healthy activities such as exercising, eating fruits or vegetables, and enjoying family meals.

8 Apr 2008

Treatment with an anti-psychotic drug found to cause changes in metabolism earlier than expected

Schizophrenia is a complex type of psychotic mental illness characterized by thoughts that are uncoupled from reality.

8 Apr 2008

Skin product decreases malignant melanoma tumor growth according to study

A new study presented at the Experimental Biology Annual Meeting shows that a proprietary blend extracted from canola, Dermytol, produces a pronounced reduction of malignant melanoma cell growth. Dermytol, a proprietary compound developed by KGK Synergize Inc., a biotechnology company in Ontario Canada, is designed to protect skin cells from damage that may lead to skin cancer.

8 Apr 2008